Intercept to Announce Third Quarter 2022 Financial Results on November 1, 2022
Intercept Pharmaceuticals (Nasdaq: ICPT) will release its Q3 2022 financial results on November 1, 2022, prior to market opening. A conference call and audio webcast will follow at 8:30 a.m. ET. Investors can join via the company’s investor page, and questions can be submitted in advance for participation.
Intercept focuses on developing therapeutics for non-viral liver diseases, such as primary biliary cholangitis and nonalcoholic steatohepatitis. For more details, visit their official website.
- Anticipation of Q3 2022 financial results may generate investor interest.
- Focus on progressive liver diseases positions the company in a niche market.
- None.
MORRISTOWN, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its third quarter 2022 financial results prior to market open on Tuesday, November 1, 2022. The announcement will be followed by a conference call and audio webcast at 8:30 a.m. ET.
Participants can access the conference call live via webcast which will be available on the investor page of our website at http://ir.interceptpharma.com. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. While not required, it is recommended you join 10 minutes prior to the event's start. A replay of the call will be available on Intercept’s website following the completion of the call.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.
Contact
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
FAQ
When will Intercept Pharmaceuticals announce its Q3 2022 financial results?
What time is the conference call for Intercept Pharmaceuticals Q3 results?
How can I listen to Intercept Pharmaceuticals' financial results announcement?
What diseases does Intercept Pharmaceuticals focus on?
